Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what his timetable is for publishing the findings of the public consultation on making hormone replacement therapy products available without the need for prescription.

The Medicines and Healthcare products Regulatory Agency’s (MHRA) consultation on reclassifying a locally acting hormone replacement therapy (HRT), Gina 10 microgram vaginal tablets, from a prescription-only to pharmacy medicine has closed. The MHRA is currently reviewing the responses received and the outcome of the consultation will be available in due course. The consultation did not apply to other HRT products.